Clinical Trial Update: Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate [NA]

View source ↗

Summary

A completed clinical trial evaluating an antioxidant from microencapsulated red pomegranate in HIV-positive patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Microencapsulated Red Pomegranate Extract (pomegranate extract (microencapsulated))

Snippet

Sponsor: Universidad Autónoma del Estado de Hidalgo | Conditions: HIV Positive | NA | Status: COMPLETED